At the 2024 Annual Urology Advocacy Summit in Washington, DC, the Sexual Medicine Society of North America held a session focused on the health and psychological benefits of urological prosthetics in prostate cancer survivors. Dr Hossein Sadeghi-Nejad moderated the session, commencing with a poignant quote by Dr Litwin and colleagues, stressing the need to enhance not only survival but also the quality of life for men with localized prostate cancer. Highlighting the paper from their own group, and specifically looking at the SEER database between 2006 and 2011, it was demonstrated that of 13,812 patients diagnosed with erectile dysfunction in a cohort of more than 30,000 radical prostatectomy and radiation therapy patients, only 3.6% of the radical prostatectomy group and 1.4% of the radiation group underwent penile prosthesis surgery as treatment for erectile dysfunction, illustrating likely underutilization of this treatment modality.